TTY Biopharm Company Limited (TPEX:4105)

TTY Biopharm Company Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	19,718	18,102	19,991	20,737	17,107	17,057
Market Cap Growth	8.04%	-9.45%	-3.60%	21.22%	0.29%	-16.75%
Enterprise Value	20,075	18,292	20,061	20,686	16,707	17,498
Last Close Price	79.30	68.90	72.83	72.32	57.19	54.16
PE Ratio	12.49	12.49	17.72	18.95	20.56	18.46
Forward PE	-	12.86	14.81	17.45	16.54	13.10
PS Ratio	3.17	3.07	3.63	4.10	3.77	4.04
PB Ratio	2.85	2.41	3.07	3.33	2.97	2.81
P/TBV Ratio	3.42	2.84	3.46	3.84	3.39	3.21
P/FCF Ratio	13.57	14.79	19.85	18.12	14.30	47.61
P/OCF Ratio	12.61	13.42	18.42	16.78	13.62	32.41
EV/Sales Ratio	3.23	3.10	3.64	4.09	3.68	4.14
EV/EBITDA Ratio	9.07	11.52	12.81	14.69	12.82	15.75
EV/EBIT Ratio	9.97	13.12	14.62	16.85	14.65	18.28
EV/FCF Ratio	13.82	14.94	19.92	18.08	13.97	48.85
Debt / Equity Ratio	0.32	0.23	0.29	0.29	0.37	0.35
Debt / EBITDA Ratio	1.22	1.08	1.19	1.28	1.65	1.93
Debt / FCF Ratio	1.52	1.40	1.85	1.58	1.79	5.98
Asset Turnover	0.59	0.57	0.56	0.54	0.49	0.45
Inventory Turnover	2.19	2.10	2.08	2.05	1.71	1.64
Quick Ratio	1.24	1.56	1.62	1.35	1.23	1.42
Current Ratio	1.77	2.02	2.08	1.73	1.56	1.88
Return on Equity (ROE)	24.75%	21.68%	17.56%	18.38%	13.89%	15.98%
Return on Assets (ROA)	9.68%	8.40%	8.81%	8.12%	7.64%	6.33%
Return on Capital (ROIC)	11.21%	9.91%	10.46%	9.62%	8.84%	7.33%
Return on Capital Employed (ROCE)	21.80%	17.40%	18.80%	18.40%	18.30%	14.10%
Earnings Yield	8.03%	8.01%	5.64%	5.28%	4.86%	5.42%
FCF Yield	7.37%	6.76%	5.04%	5.52%	6.99%	2.10%
Dividend Yield	5.28%	6.09%	4.81%	4.70%	5.24%	7.39%
Payout Ratio	65.98%	60.04%	74.91%	68.16%	119.56%	107.62%
Buyback Yield / Dilution	-0.03%	-0.04%	-0.03%	0.02%	0.00%	-0.03%
Total Shareholder Return	5.25%	6.06%	4.78%	4.72%	5.25%	7.36%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.